Loading organizations...
Loading organizations...
T cell therapies targeting cancer neo-antigens for personalized treatment.
Neogene Therapeutics has raised $110.0M across 1 funding round.
Neogene Therapeutics has raised $110.0M in total across 1 funding round.
Neogene Therapeutics has raised $110.0M in total across 1 funding round.
Neogene Therapeutics's investors include Oleg Nodelman, Rafaèle Tordjman, Martin Murphy, Polaris Partners, Pontifax, TPG, Two River, Vida Ventures.
Neogene Therapeutics has raised $110.0M across 1 funding round. Most recently, it raised $110.0M Series A in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 14, 2020 | $110.0M Series A | Oleg Nodelman, Rafaèle Tordjman, Martin Murphy | Polaris Partners, Pontifax, TPG, Two River, Vida Ventures |